Literature DB >> 8241513

Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days.

J A Christian1, A H Rebar, G D Boon, P S Low.   

Abstract

We have evaluated senescence related changes in canine red blood cells (RBCs) using the biotinylation system, where RBCs are labeled in vivo with biotin at the beginning of their life span, and retrieved from circulation on immobilized avidin at the end of their life span. This approach avoids the controversial use of density gradient centrifugation to collect presumably old RBCs. Furthermore, the dog is an appropriate model for human RBC senescence because it has a low degree of random RBC loss and a similarly long RBC life span (approximately 110 days). Two dogs had 97% to 100% of their circulating RBCs biotinylated by infusion of N-hydroxysuccinimido biotin (Clontech, Palo Alto, CA; Calbiochem, La Jolla, CA) dissolved in dimethyl sulfoxide. At postbiotinylation days 104 and 107 for one dog and day 110 for the other dog, biotinylated RBCs were isolated by magnetic cell sorting and analyzed for the presence of autologous IgG using 125I-labeled sheep-antidog IgG (SAD IgG). On all 3 days, there were at least three times more SAD IgG molecules per RBC on senescent biotinylated RBCs than on control (unfractionated) RBCs (day 104: 11,677 v 3,399; day 107: 6,710 v 2,115; day 110: 6,042 v 1,838 molecules of SAD IgG per senescent v control RBC). Furthermore, it is unlikely that an immune response to the conjugated biotin had been elicited, because fresh in vitro biotinylated RBCs that were incubated in autologous plasma (taken after exposure to circulating biotinylated RBCs for 113 days) and then exposed to the SAD IgG showed no increase in antibody binding over control (non-biotinylated) RBCs (1,431 v 1,378 cpm/10(8) biotinylated v control RBCs; P > .20). These results suggest that senescence of canine biotinylated RBCs is characterized by binding of autologous IgG and that antibiotin antibodies do not contribute to this process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241513

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Influence of transfusion technique on survival of autologous red blood cells in the dog.

Authors:  Ruth I McDevitt; Craig G Ruaux; Wendy I Baltzer
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2011-05-10

2.  Measurement of red cell lifespan and aging.

Authors:  Robert S Franco
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

3.  Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells.

Authors:  R S Franco; J Lohmann; E B Silberstein; G Mayfield-Pratt; M Palascak; T A Nemeth; C H Joiner; M Weiner; D L Rucknagel
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

4.  Determination of RBC Survival in C57BL/6 and C57BL/6-Tg(UBC-GFP) Mice.

Authors:  Urshulaa Dholakia; Sheila Bandyopadhyay; Eldad A Hod; Kevin A Prestia
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

5.  Oxidative stress and caspase-mediated fragmentation of cytoplasmic domain of erythrocyte band 3 during blood storage.

Authors:  Sara Rinalducci; Emanuela Ferru; Barbara Blasi; Francesco Turrini; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

6.  Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.

Authors:  Nisha G Sosale; Tahereh Rouhiparkouhi; Andrew M Bradshaw; Rumiana Dimova; Reinhard Lipowsky; Dennis E Discher
Journal:  Blood       Date:  2014-11-19       Impact factor: 22.113

Review 7.  Measurement of posttransfusion red cell survival with the biotin label.

Authors:  Donald M Mock; John A Widness; Peter Veng-Pedersen; Ronald G Strauss; Jose A Cancelas; Robert M Cohen; Christopher J Lindsell; Robert S Franco
Journal:  Transfus Med Rev       Date:  2014-04-05

8.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Authors:  Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

9.  Changes in the properties of normal human red blood cells during in vivo aging.

Authors:  Robert S Franco; M Estela Puchulu-Campanella; Latorya A Barber; Mary B Palascak; Clinton H Joiner; Philip S Low; Robert M Cohen
Journal:  Am J Hematol       Date:  2012-10-31       Impact factor: 10.047

10.  A novel assay to trace proliferation history in vivo reveals that enhanced divisional kinetics accompany loss of hematopoietic stem cell self-renewal.

Authors:  Jens M Nygren; David Bryder
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.